ArriVent BioPharma Reports Second Quarter 2026 Financial Results
Go back to ArriVent BioPharma Reports Second Quarter 2026 Financial Results| (NASDAQ: AVBP) | Delayed: 30.08 +0.08 (0.27%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $30.00 | 52 Week High | $ | |||
| Open | $30.13 | 52 Week Low | $ | |||
| Day High | $30.45 | P/E | N/A | |||
| Day Low | $29.46 | EPS | $ | |||
| Volume | 109,849 | |||||

